Analysed LB PHARMACEUTICALS INC (LBRX:NASDAQ) News Sources
LB Pharmaceuticals Highlights LB-102 Phase 3 Schizophrenia Path, Funding Runway to 2029 at Needham
17-04-2026
marketbeat.com
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
09-04-2026
yahoo.com
LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)
27-03-2026
yahoo.com
LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
26-03-2026
yahoo.com
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
25-03-2026
yahoo.com
LB Pharmaceuticals CEO Maps LB-102 Milestones, Says Pipeline Fully Funded Into Q2 2029
20-03-2026
marketbeat.com
Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight
11-03-2026
yahoo.com
LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
09-03-2026
yahoo.com
What is the current price of LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The current price of LB PHARMACEUTICALS INC (LBRX:NASDAQ) is $31.78.
LB PHARMACEUTICALS INC (LBRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of LB PHARMACEUTICALS INC (LBRX:NASDAQ) since the previous trading day is $0.11.
LB PHARMACEUTICALS INC (LBRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of LB PHARMACEUTICALS INC (LBRX:NASDAQ) since the previous trading day is 0.3473%.
What is the most recent average sentiment score for LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The most recent average sentiment score for LB PHARMACEUTICALS INC (LBRX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The most recent sentiment for LB PHARMACEUTICALS INC (LBRX:NASDAQ) is .
SEC-8K** Filing Available For LB PHARMACEUTICALS INC (LBRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.